Moderna is counting on its product pipeline to resuscitate its ailing stock
Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...
Investor's Business Daily on MSN11h
Airbnb Stock Jumps As Sales Growth Accelerates, Guidance Eases Concerns
Airbnb Eases Margin Concerns. While Airbnb's sales guidance for the current quarter was slightly below estimates, Wedbush ...
Investor's Business Daily on MSN12h
Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble
Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.
Equal-weight S&P 500 clings to gain as these sectors trade in the green
A gauge of the U.S. equities that equally weights stocks in the S&P 500 index was clinging to a slight gain on Friday afternoon. The Invesco S&P 500 Equal Weight ETF was up 0.1% in afternoon trading, ...
Informatica's stock plunges after 'messy' Q4 results, but analysts see positives
Informatica shares are down 49% in the last 12 months, compared with the S&P 500 index's SPX gain of 22.4%. Shares of rival International Business Machines Corp. (IBM) are up 39.3% in the last 12 ...
Can Lofty U.S. Stock Market Valuations Be Safely Ignored?
The persistent rise in US equities is helping promote a view that the relationships of old for stocks and traditional measures for value-oriented investing strategies no longer apply.